Journal articles on the topic 'CNS drugs'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'CNS drugs.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Generali, Joyce A. "CNS and Psychiatric Drugs." Hospital Pharmacy 37, no. 8 (August 2002): 888–94. http://dx.doi.org/10.1177/001857870203700802.
Full textMarsden, Charles A., and S. Clare Stanford. "CNS Drugs III: Psychotherapeutics." Expert Opinion on Investigational Drugs 9, no. 8 (August 2000): 1923–29. http://dx.doi.org/10.1517/13543784.9.8.1923.
Full textVastag, B. "More Children on CNS Drugs." JAMA: The Journal of the American Medical Association 287, no. 15 (April 17, 2002): 1930—a—1930. http://dx.doi.org/10.1001/jama.287.15.1930-a.
Full textVastag, Brian. "More Children on CNS Drugs." JAMA 287, no. 15 (April 17, 2002): 1930. http://dx.doi.org/10.1001/jama.287.15.1930-jha20004-2-1.
Full textSchou, Magnus, and Katarina Varnäs. "PET microdosing of CNS drugs." Clinical and Translational Imaging 5, no. 3 (March 23, 2017): 291–98. http://dx.doi.org/10.1007/s40336-017-0226-y.
Full textTobinick, Edward Lewis. "Perispinal Delivery of CNS Drugs." CNS Drugs 30, no. 6 (April 27, 2016): 469–80. http://dx.doi.org/10.1007/s40263-016-0339-2.
Full text&NA;. "Elderly less tolerant of CNS drugs." Reactions Weekly &NA;, no. 501 (May 1994): 3. http://dx.doi.org/10.2165/00128415-199405010-00005.
Full textGhose, Karabi. "Prescribing CNS Drugs for Elderly Patients." Drugs & Aging 4, no. 4 (April 1994): 275–84. http://dx.doi.org/10.2165/00002512-199404040-00001.
Full textBOSCHERT, SHERRY. "CNS Drugs And Cognitive Decline Tied." Family Practice News 38, no. 4 (February 2008): 34. http://dx.doi.org/10.1016/s0300-7073(08)70241-x.
Full textPreskorn, Sheldon H. "CNS Drug Development: Part I: The Early Period of CNS Drugs." Journal of Psychiatric Practice 16, no. 5 (September 2010): 334–39. http://dx.doi.org/10.1097/01.pra.0000388628.44405.c0.
Full textFregni, Felipe. "CNS or Classic Drugs for the Treatment of Pain in Functional Dyspepsia? A Systematic Review and Meta-Analysis of the Literature." October 2008 5;11, no. 10;5 (October 14, 2008): 597–609. http://dx.doi.org/10.36076/ppj.2008/11/597.
Full textKharkar, Prashant S. "Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets." F1000Research 3 (March 21, 2014): 40. http://dx.doi.org/10.12688/f1000research.3-40.v2.
Full textSaganuwan, Saganuwan Alhaji. "Chirality of Central Nervous System (CNS) Acting Drugs: A Formidable Therapeutic Hurdle Against CNS Diseases." Central Nervous System Agents in Medicinal Chemistry 19, no. 3 (October 31, 2019): 171–79. http://dx.doi.org/10.2174/1871524919666190624150214.
Full text&NA;. "CNS adverse events induced by antimalarial drugs." Reactions Weekly &NA;, no. 556 (June 1995): 3. http://dx.doi.org/10.2165/00128415-199505560-00007.
Full textKennedy, Gina M., and Samden D. Lhatoo. "CNS Adverse Events Associated with Antiepileptic Drugs." CNS Drugs 22, no. 9 (2008): 739–60. http://dx.doi.org/10.2165/00023210-200822090-00003.
Full textMart??nez-Cano, H. "Seizures following withdrawal of CNS depressor drugs." Behavioural Pharmacology 6, SUPPLEMENT 1 (May 1995): 85. http://dx.doi.org/10.1097/00008877-199505001-00098.
Full textLam, Y. W. Francis. "CNS‐active drugs and risk of fall." Brown University Psychopharmacology Update 30, no. 7 (June 8, 2019): 2–3. http://dx.doi.org/10.1002/pu.30445.
Full textCacabelos, Ramón. "Pharmacogenomics of Central Nervous System (CNS) Drugs." Drug Development Research 73, no. 8 (October 18, 2012): 461–76. http://dx.doi.org/10.1002/ddr.21039.
Full textRao, Kavitha S., Anuja Ghorpade, and Vinod Labhasetwar. "Targeting anti-HIV drugs to the CNS." Expert Opinion on Drug Delivery 6, no. 8 (June 30, 2009): 771–84. http://dx.doi.org/10.1517/17425240903081705.
Full textSourkes, Theodore L. "Early clinical neurochemistry of CNS-active drugs." Molecular and Chemical Neuropathology 17, no. 1 (August 1992): 21–30. http://dx.doi.org/10.1007/bf03159978.
Full textMöhler, H., and U. Rudolph. "Selective GABAA circuits for novel CNS drugs." Drug Discovery Today: Therapeutic Strategies 1, no. 1 (September 2004): 117–23. http://dx.doi.org/10.1016/j.ddstr.2004.08.019.
Full textPolianchik, D. E., V. Yu Grigor’ev, G. I. Sandakov, A. V. Yarkov, S. O. Bachurin, and O. A. Raevskii. "Binary Classification of CNS and PNS Drugs." Pharmaceutical Chemistry Journal 50, no. 12 (March 2017): 800–804. http://dx.doi.org/10.1007/s11094-017-1535-1.
Full textGovoni, S., F. Battaini, M. Trabucchi, and R. Paoletti. "CNS effects of calcium channel blocking drugs." International Journal of Developmental Neuroscience 3, no. 4 (1985): 440. http://dx.doi.org/10.1016/0736-5748(85)90135-2.
Full textSturman, Gillian. "Histaminergic drugs as modulators of CNS function." Pflügers Archiv European Journal of Physiology 431, S6 (November 1996): R223—R224. http://dx.doi.org/10.1007/bf02346349.
Full textAshley, Elizabeth Dodds. "Antifungal Drugs: Special Problems Treating Central Nervous System Infections." Journal of Fungi 5, no. 4 (October 11, 2019): 97. http://dx.doi.org/10.3390/jof5040097.
Full textSaganuwan, Saganuwan Alhaji. "Chemistry and Effects of Brainstem Acting Drugs." Central Nervous System Agents in Medicinal Chemistry 19, no. 3 (October 31, 2019): 180–86. http://dx.doi.org/10.2174/1871524919666190620164355.
Full text&NA;. "Prescribing CNS-active drugs during pregnancy and lactation." Reactions Weekly &NA;, no. 782 (December 1999): 2. http://dx.doi.org/10.2165/00128415-199907820-00001.
Full textMorgan, Althea, and David Clark. "CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs." CNS Drugs 9, no. 4 (1998): 281–90. http://dx.doi.org/10.2165/00023210-199809040-00004.
Full textWynn, Heather E., Richard C. Brundage, and Courtney V. Fletcher. "Clinical Implications of CNS Penetration of Antiretroviral Drugs." CNS Drugs 16, no. 9 (2002): 595–609. http://dx.doi.org/10.2165/00023210-200216090-00002.
Full textHroch, Lukas, Laura Aitken, Ondrej Benek, Martin Dolezal, Kamil Kuca, Frank Gunn-Moore, and Kamil Musilek. "Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs." Current Medicinal Chemistry 22, no. 6 (January 20, 2015): 730–47. http://dx.doi.org/10.2174/0929867322666141212120631.
Full text&NA;. "Recommendations for using CNS-active drugs in breastfeeding." Reactions Weekly &NA;, no. 666 (August 1997): 2. http://dx.doi.org/10.2165/00128415-199706660-00001.
Full textSantini, Stefano Angelo, Francesco Panza, Madia Lozupone, Antonello Bellomo, Antonio Greco, and Davide Seripa. "Genetics of tailored medicine: Focus on CNS drugs." Microchemical Journal 136 (January 2018): 164–69. http://dx.doi.org/10.1016/j.microc.2017.02.018.
Full textSchuster, Charles R., and Jack Henningfield. "Conference on abuse liability assessment of CNS drugs." Drug and Alcohol Dependence 70, no. 3 (June 2003): S1—S4. http://dx.doi.org/10.1016/s0376-8716(03)00095-4.
Full textRomach, Myroslava K., Kerri A. Schoedel, and Edward M. Sellers. "Human abuse liability evaluation of CNS stimulant drugs." Neuropharmacology 87 (December 2014): 81–90. http://dx.doi.org/10.1016/j.neuropharm.2014.04.014.
Full textSourkes, Theodore L. "Early clinical neurochemistry of CNS-active drugs. Bromides." Molecular and Chemical Neuropathology 14, no. 2 (April 1991): 131–42. http://dx.doi.org/10.1007/bf03159932.
Full textGray, John A., and Bryan L. Roth. "Developing selectively nonselective drugs for treating CNS disorders." Drug Discovery Today: Therapeutic Strategies 3, no. 4 (December 2006): 413–19. http://dx.doi.org/10.1016/j.ddstr.2006.11.009.
Full textRichardson, Peter J., Silvia Ottaviani, Alessandro Prelle, Justin Stebbing, Giacomo Casalini, and Mario Corbellino. "CNS penetration of potential anti-COVID-19 drugs." Journal of Neurology 267, no. 7 (May 2, 2020): 1880–82. http://dx.doi.org/10.1007/s00415-020-09866-5.
Full textReddy, D. Samba. "Novel Drugs and Biologics of 2016: A Boom for Neurodrugs in the Pipelin." International Journal of Pharmaceutical Sciences and Nanotechnology 10, no. 5 (September 30, 2017): 3809–14. http://dx.doi.org/10.37285/ijpsn.2017.10.5.1.
Full textYamamoto, Marumi, Yoshinori Ohta, Mio Sakuma, Chisa Matsumoto, and Takeshi Morimoto. "Adverse Drug Events due to Central Nervous System Depressant Drugs in Pediatric Patients With or Without Surgery." Journal of Pediatric Pharmacology and Therapeutics 25, no. 4 (May 1, 2020): 295–302. http://dx.doi.org/10.5863/1551-6776-25.4.295.
Full textManallack, David T. "The pKa Distribution of Drugs: Application to Drug Discovery." Perspectives in Medicinal Chemistry 1 (January 2007): 1177391X0700100. http://dx.doi.org/10.1177/1177391x0700100003.
Full textSaleh, Mohammed A. A., Chi Fong Loo, Jeroen Elassaiss-Schaap, and Elizabeth C. M. De Lange. "Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations." Journal of Pharmacokinetics and Pharmacodynamics 48, no. 5 (June 17, 2021): 725–41. http://dx.doi.org/10.1007/s10928-021-09768-7.
Full textGardner, Shea N. "Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution." Journal of Theoretical Medicine 2, no. 3 (2000): 215–32. http://dx.doi.org/10.1080/10273660008833047.
Full textHasan, Zaidi, Nirwan, Ghori, Javid, Ahmadi, and Babar. "Use of Central Nervous System (CNS) Medicines in Aged Care Homes: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine 8, no. 9 (August 23, 2019): 1292. http://dx.doi.org/10.3390/jcm8091292.
Full textNwogu, Jacinta Nwamaka, Qing Ma, Chinedum Peace Babalola, Waheed Adeola Adedeji, Gene D. Morse, and Babafemi Taiwo. "Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals." AIDS Research and Treatment 2016 (2016): 1–13. http://dx.doi.org/10.1155/2016/2587094.
Full textAlelyunas, Yun W., James R. Empfield, Dennis McCarthy, Russell C. Spreen, Khanh Bui, Luciana Pelosi-Kilby, and Cindy Shen. "Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate." Bioorganic & Medicinal Chemistry Letters 20, no. 24 (December 2010): 7312–16. http://dx.doi.org/10.1016/j.bmcl.2010.10.068.
Full textPaul, Steven. "CNS drug discovery in the 21st century." British Journal of Psychiatry 174, S37 (February 1999): 23–25. http://dx.doi.org/10.1192/s0007125000293628.
Full textSaganuwan, Saganuwan A. "Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs." Central Nervous System Agents in Medicinal Chemistry 20, no. 1 (March 3, 2020): 3–12. http://dx.doi.org/10.2174/1871524919666190621160323.
Full textDuarte, Diana, Armando Cardoso, and Nuno Vale. "Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs." International Journal of Molecular Sciences 22, no. 14 (July 10, 2021): 7408. http://dx.doi.org/10.3390/ijms22147408.
Full textAHMED, SAIMA, MUHAMMAD ASADULLAH, and ATA-UR REHMAN. "EFFECT OF DRUGS;." Professional Medical Journal 20, no. 01 (December 10, 2012): 103–13. http://dx.doi.org/10.29309/tpmj/2013.20.01.586.
Full textLochhead, Jeffrey J., and Thomas P. Davis. "Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration." Pharmaceutics 11, no. 11 (November 12, 2019): 598. http://dx.doi.org/10.3390/pharmaceutics11110598.
Full text